VT103
VT103 is an orally active and selective inhibitor of TEAD1 protein palmitoylation and is an analog of VT101. VT103 has potential antitumor activity by inhibiting YAP/TAZ-TEAD-promoted gene transcriptionment, blocking TEAD auto-palmitoylation, and blocking the interaction between YAP/TAZ and TEAD.VT103 can be used in the study of HER2-positive breast cancer, prostate cancer, and triple-negative breast cancer.
Product Specifications
CAS Number
2290608-13-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
410.41
Molecular Formula
C18H17F3N4O2S
Notes
Research use only, not for human use.
Receptor
YAP
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6212907-01 0.1 mL
OAS1 (2', 5'-Oligoadenylate Synthetase 1, (2-5')oligo(A) Synthase 1, 2-5A Synthase 1, E18/E16, p46/p42 OAS, OIAS) (MaxLight 550)
Sign In for Pricing
View Details MBS6212907-02 5x 0.1 mL
OAS1 (2', 5'-Oligoadenylate Synthetase 1, (2-5')oligo(A) Synthase 1, 2-5A Synthase 1, E18/E16, p46/p42 OAS, OIAS) (MaxLight 550)
Sign In for Pricing
View Details 
